# Lilly del Caribe, Inc. – FDA Inspection, Sep 15, 2010

Source: https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/45f81be8-2bfe-4200-b122-82cea0abdbfb
Source feed: FDA_Inspections

> FDA inspection 682973 of Lilly del Caribe, Inc., September 15, 2010. Classification: No Action Indicated (NAI). 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 682973
- Company Name: Lilly del Caribe, Inc.
- Inspection Date: 2010-09-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1321482 - 2026-05-12
- [FDA Inspection 1198613 - 2023-02-17](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/c2c92c4c-c540-4128-90a5-30550b167b83)
- FDA Inspection 1069980 - 2018-09-27
- FDA Inspection 974723 - 2016-06-01
- FDA Inspection 868382 - 2014-02-21

Company: https://www.keypedia.com/companies/lilly-del-caribe-inc/7961ecde-19e4-4ccc-9701-c1979bc57aaa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c